In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
Science on heart failure

Watch on-demand webinars on Late-Breaking Trials, and explore clinical cases, important HFA position papers, and more.

 

Access now

European Journal of Heart Failure

Advancing Knowledge in the Field of Heart Failure Management

 

The European Journal of Heart Failure (EJHF) is dedicated to the advancement of knowledge in the field of heart failure management.

The journal publishes reviews and editorials to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as clinical, social and population sciences all form part of the discipline.

Fast Facts

  • Editor-in-chief: Marco Metra (IT)
  • Current volume: 24 (year 2022)
  • Issues per subscription: 12
  • Impact Factor 2020:  15.534

 

Editor in chief History

 

Name Start Date End Date
Professor John Cleland 01/01/1999 31/12/2004
Professor Karl Swedberg 01/01/2005 31/12/2009
Professor Dirk J. Van Veldhuisen 01/01/2010 31/12/2014
Professor Marco Metra 01/01/2015  
Updates on latest articles

Updates on latest articles

 

Receive the table of contents in your mailbox.

Track topics and authors important to you and receive articles in your mailbox.

For Authors

Before being published, all manuscripts go through double-blind peer review by experienced international experts.


Most recent articles from EJHF

17 Jun 2022
Baroreflex activation therapy with the barostim™ device in patients with heart failure with reduced ejection fraction: A patient level meta‐analysis of randomized controlled trials
Author(s): AJS Coats, WT Abraham, MR Zile, JA Lindenfeld, FA Weaver, M Fudim, J Bauersachs, S Duval, E Galle, F Zannad
15 Jun 2022
Factors associated with health‐related quality of life in heart failure in 23 000 patients from 40 countries: results of the G‐CHF research programme
Author(s): Isabelle Johansson, Kumar Balasubramanian, Shrikant Bangdiwala, Lisa Mielniczuk, Camilla Hage, Sanjib Kumar Sharma, Kelley Branch, Jun Zhu, Kristian Kragholm, Karen Sliwa, Francois Alla, Gerald Yonga, Ambuj Roy, Andres Orlandini, Alex Grinvalds, Tara McCready, Nana Pogosova, Stefan Störk, John J.V. McMurray, David Conen, Salim Yusuf,  on behalf of the GCHF Investigators
17 Jun 2022
Early changes in estimated glomerular filtration rate post‐initiation of empagliflozin in EMPEROR‐Reduced
Author(s): Faiez Zannad, João Pedro Ferreira, John Gregson, Bettina Johanna Kraus, Michaela Mattheus, Sibylle Jenny Hauske, Javed Butler, Gerasimos Filippatos, Christoph Wanner, Stefan D. Anker, Stuart J. Pocock, Milton Packer, for the EMPEROR‐Reduced Trial Committees and Investigators
15 Jun 2022
Left atrial volume index and outcome after transcatheter edge‐to‐edge valve repair for secondary mitral regurgitation
Author(s): Christos Iliadis, Daniel Kalbacher, Philipp Lurz, Aniela Monica Petrescu, Mathias Orban, Tania Puscas, Laura Lupi, Laura Stazzoni, Gustavo Pires‐Morais, Benedikt Koell, Christian Besler, Tobias Friedrich Ruf, Lukas Stolz, Noemie Tence, Marianna Adamo, Cristina Giannini, Cláudio Guerreiro, Martin Hellmich, Stephan Baldus, Niklas Schofer, Holger Thiele, Ralph Stephan von Bardeleben, Jörg Hausleiter, Nicole Karam, Marco Metra, Anna Sonia Petronio, Bruno Melica, Roman Pfister